Prof William Gradishar - Robert H. Lurie Comprehensive Cancer Center, USA
Combining chemotherapy with a drug widely used to treat liver and kidney cancer has offered advanced breast cancer patients with HER2-negative tumors significant improvement in overall response rate and time-to-disease progression. Official San Antonio Breast Cancer Symposium press conference.